Earlier this year, Rheonix received a fast-track Small Business Innovation Research grant to develop a “dual use” assay capable of simultaneously detecting host anti-HIV antibodies and HIV viral RNA from either blood or saliva samples.
Read More
The company’s development effort is targeting a new test to deliver lab-quality results from a few drops of fingerstick-collected blood at remote patient sites.
Read More
The company has launched its next-generation wireless rapid diagnostic system for detection of group A Strep, influenza A and B, and respiratory syncytial virus.
Read More
Commission funding will be used to validate the clinical utility and cost-effectiveness of the ImmunoXpert, a diagnostic test that distinguishes bacterial from viral infections.
Read More
The patent applications expand the company’s growing intellectual property portfolio, and include an immunoassay system for the detection of antibodies to such pathogens as Zika and other flaviviruses.
Read More